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Abstract 
 
Purpose: Caffeine, often in the form of coffee, is frequently supplemented by athletes in an 
attempt to facilitate improved performance during exercise. The aim of the present study was to 
investigate the effectiveness of coffee ingestion as an ergogenic aid prior to a one-mile (1609 m) 
race. Methods: In a double-blind, randomised, crossover, placebo-controlled design 13 trained 
male runners completed a one-mile race 60 minutes following the ingestion of 0.09 g·kg-1 coffee 
(COF), 0.09 g·kg-1 decaffeinated coffee (DEC), or a placebo (PLA). All trials were dissolved in 
300 ml of hot water. Results: The race completion time was 1.3% faster following the ingestion 
of COF (04:35:37 ± 00:10:51 mm:ss) compared with DEC (04:39:14 ± 00:11:21  mm:ss; P=0.018; 
95%CI: -0.11, -0.01; d=0.32) and 1.9% faster compared with PLA (04:41:00 ± 00:09:57 mm:ss; 
P=0.006; 95%CI: -0.15, -0.03; d=0.51). A large trial and time interaction for salivary caffeine 
concentration was observed (P<0.001; 2P =0.69) with a very large increase (6.40 ± 1.57 μg·ml
-1, 
95%CI: 5.5, 7.3; d=3.86) following the ingestion of COF. However, only a trivial difference 
between DEC and PLA was observed (P=0.602; 95%CI: -0.09, 0.03; d=0.17). Furthermore, only 
trivial differences for blood glucose (P=0.839; 2P =0.02) and lactate (P=0.096; 2P =0.18), and 
maximal heart rate (P=0.286; 2P =0.13) were observed between trials. Conclusions: The results 
of the present study show that 60 minutes after ingesting 0.09 g·kg-1 of caffeinated coffee one-mile 
race performance was enhanced by 1.9% and 1.3% compared with placebo and decaffeinated 
coffee respectively, in trained male runners. 
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Introduction 
 
Caffeine, often in the form of coffee1, is frequently supplemented by athletes in an attempt to 
facilitate improved performance during exercise. However, the available research typically focuses 
on the ingestion of 3-8 mg·kg-1 of anhydrous caffeine rather than coffee1. Caffeine non-selectively 
blocks both adenosine receptors and competitively inhibits the action of adenosine, which during 
exercise, can lower pain perception, increase neuro-excitability and sustain motor unit firing2. 
Therefore, adenosine receptor antagonism is the leading hypothesis as to how caffeine could have 
an ergogenic effect on exercise performance2. Despite this, Astorino and Roberson3 concluded that 
the mechanism by which caffeine provides an ergogenic effect in high intensity exercise is likely 
to be multifactorial, with central factors such as adenosine antagonism being the most probable 
mechanism, but with reductions in perceived exertion, and increased reaction time, cognition, and 
mood also having an influence on performance.  
 
Recently, there has been debate as to whether the same ergogenic benefits observed from caffeine 
ingestion can be obtained from consuming caffeine in the form of coffee, especially as Liguori et 
al.4 reported that peak salivary caffeine concentration was faster and higher following coffee 
ingestion, compared with a caffeine capsule. However, Graham et al.5 concluded that only 4.5 
mg·kg-1 of anhydrous caffeine increased exercise distance by 2-3 km when running at 85% OV 2max 
until voluntary exhaustion and proposed that chlorogenic acids, and possibly other ingredients 
within coffee, nullified the ergogenic benefits of caffeine. In contrast, Hodgson et al.6 compared 5 
mg·kg-1 of anhydrous caffeine to coffee during a cycling time trial lasting approximately 75 min 
and observed that both coffee and caffeine ingestion were beneficial to exercise performance by 
similar magnitudes (~5%). Furthermore, Trexler et al.7 concluded that providing 3-5 mg·kg-1 of 
caffeine in the form of coffee or anhydrous caffeine improved repeated sprint performance and 
Wiles et al.8 observed that 1500 m running performance improved by 4.2 s following the ingestion 
of 3 g of coffee (150-200 mg caffeine). In addition, Richardson and Clarke9 reported that during 
resistance exercise, the total weight lifted during back squats was 22% higher following the 
ingestion of coffee, providing 5 mg·kg-1 of caffeine, when compared with a placebo. The 
inconsistency in performance outcomes associated with coffee ingestion may be due to the blend 
of coffee ingested and consequently substantial variation in chlorogenic acid content and caffeine 
concentration of the coffee10, exercise modality11, and training status12. However, Higgins et al.1 
concluded that coffee providing 3 mg·kg-1 of caffeine may be used as an alternative to anhydrous 
caffeine to improve endurance performance. 
  
While sporting performance is more than just a physiological construct, many of the interventions 
that are researched tend to be physiological in nature, such as nutritional or training. Furthermore, 
to be a valid simulation of competitive performance, the protocol should provide similar 
physiological (and psychological) responses to actual performance13 but actual competitive events 
are seldom investigated. Consequently, with studies suggesting that coffee may improve exercise 
performance8,14, it would be beneficial to investigate the effect of coffee ingestion on actual race 
performance, as no previous study has investigated the effect of coffee ingestion on performance 
in ecologically valid situations such as a competitive race. Therefore, the aim of the present study 
was to provide an insight into the effectiveness of coffee ingestion as an ergogenic aid prior to a 
one-mile (1609 m) race in trained males. 
 
Methods 
 
Participants 
 
Fifteen trained middle distance male runners began the study, although only 13 (Mean ± SD age: 
24 ± 6 years, height: 1.81 ± 0.07 m, body mass, 69.3 ± 4.7 kg, 800 m personal best performance 
time: 01:54:43 ± 00:33:19 mm:ss, 1500 m personal best performance time: 04:07:56 ± 00:15:18 
ms:ss; one mile personal best performance time: 04:37:33 ± 00:23:25 mm:ss) completed all the 
races and are therefore included in the data analysis. In a double-blind, Latin-square 
randomisation, crossover, placebo-controlled design, participants completed a one-mile (1609 m) 
race following the ingestion of 0.09 g·kg-1 coffee (COF), 0.09 g·kg-1 decaffeinated coffee (DEC), 
or a placebo (PLA). All procedures were undertaken in accordance with the Declaration of 
Helsinki and approved by the institutional ethics committee. Participants were made fully aware 
of the exact procedures, including any risks and benefits of participation in the study before 
providing written informed consent.  
 
On separate days, trials were performed on an indoor 200 m running track with banked curves 
(temperature: 19.2 ± 0.9C and relative humidity: 45 ± 3%) at the same time (17:30) to minimise 
performance variation due to circadian variation15. Participants were instructed to abstain from 
caffeine, alcohol, and strenuous activity for 12 h prior to each race. Caffeine was not withheld for 
the 24-h period prior because it has been demonstrated that a 3 mg·kg−1 body mass dose of caffeine 
improves performance irrespective of whether a withdrawal period is imposed on habitual caffeine 
users16. In addition, the participants had not been taking any additional supplements, such as beta 
alanine, that may influence running performance for at least three months prior to data collection. 
Trials were separated by a period of seven days to ensure complete recovery. Habitual caffeine 
consumption was assessed using an adapted version of the Landrum et al.17 caffeine consumption 
questionnaire. Many participants were regular consumers of caffeine (mean ± SD: 171 ± 250 
mg·day-1 and range: 0-705 mg·day-1) with low habitual caffeine consumption defined as <300 
mg·day-1 and >300 mg·day-1 was defined as high18. In addition, a 24-hour dietary record was 
completed by each participant prior to the first race; it was then photocopied and handed back to 
the participants so that the same diet could be repeated for subsequent trials (Daily energy: 2738 
± 650 Kcal; Carbohydrate: 394 ± 95 g; Protein: 95 ± 32 g; Fat: 98 ± 29 g; Water: 2409 ± 2132 ml).  
 
Coffee Treatments 
 
Each participant competed in three races following the ingestion of the following: 0.09 g·kg-1 
coffee (Nescafé Original, Nestlé, UK; COF), 0.09 g·kg-1 decaffeinated coffee (Nescafé Original 
Decaffeinated, Nestlé, UK; DEC), and a placebo (PLA). Nescafé original coffee (from the same 
batch) was used in the coffee trials as it has been reported by Hodgson et al.6 to contain 3.4 g of 
caffeine per 100 g of coffee meaning that each participant consumed 0.09 g·kg-1 of coffee to 
achieve the 3 mg·kg-1 of caffeine required. Nescafé decaffeinated coffee was used and provides 
~0.17 mg·kg-1 of caffeine6 and was prepared in identical fashion and concentration to the coffee 
trial. All trials were dissolved in 300 ml of hot water (65.8 ± 3.1ºC) and served in lidded cups. The 
placebo trial was hot water of the same volume and temperature as the other trials with coffee 
flavour (Espresso Coffee Flavouring Compound, MSK Ingredients, UK) and colour (Brown Food 
Colouring, Lakeland, UK) added to maintain treatment blinding and to ensure all treatments tasted 
similar. Participants had a maximum of five minutes to fully consume the treatment beverage. 
 
Procedures 
 
On arrival at the athletics track the body mass of each participant was recorded and saliva and 
capillary blood samples were collected before ingesting the test drink (baseline). The participants 
then performed their usual pre-race standardised warm-up lasting 45 min, which consisted of a 
2000 m self-paced jog followed by an individual static and dynamic stretching programme and 
ending with 3 × 80 m strides. Then, 60 minutes after the ingestion of the fluid, further saliva and 
capillary blood samples were collected (post-warm-up) and the one-mile race was run. Collection 
of saliva and blood samples were repeated post-race. No encouragement was given and watches 
were removed. The one mile was timed using electronic timing lights (ALGE Timing GmbH, 
Lustenau, Austria). Time to completion was not given to the participants until after the end of the 
study. To ensure maximum effort, the races were handicapped based on the participants’ personal 
best time and adjusted based on their performance for the following race to ensure each trial was 
a competitive race e.g. a participant with a one-mile personal best of 04:22 mm:ss started 3 s after 
a participant with a personal best of 04:25 mm:ss. Furthermore, the participants received £2 for 
each place in every race i.e. £2 for 13th and £26 for 1st and an additional £50 gift voucher for the 
overall winner based on accumulated prize money.   
 
Measurements  
 
Heart rate (HR) was measured throughout each race using a short-range telemetry HR transmitter 
strap recording at 1 s intervals (Polar Team 2 System, Polar Electro Oy, Kempele, Finland). Saliva 
samples (minimum 0.5 ml by the passive drool technique) were obtained immediately before fluid 
ingestion to establish compliance with the washout period, one-hour post-ingestion and following 
the race. Participants were instructed to expectorate into a 20-ml plastic cup, and the sample was 
then transferred to a capped glass vial that was immediately placed in a portable −20°C freezer 
before being transferred to a −80°C freezer for subsequent analysis of caffeine concentration using 
a standard enzyme-linked immunoassay kit (Caffeine ELISA Kit; Creative Diagnostics, Shirley, 
USA). At the same time points, a capillary blood sample was drawn from the index finger for 
determination of blood glucose and lactate concentrations (Biosen C-line, EKF-diagnostic GmbH, 
Germany).  
 
Data Analysis 
 
An a priori power calculation based for race time revealed that a sample size of ten participants 
were necessary to detect a statistical difference given an estimated effect size of 0.5, a 1-β error 
probability of 0.8 and a P value of less than 0.05. Data are reported as the mean ± the standard 
deviation (SD). The Shapiro-Wilk test was applied to the data to assess for a normal distribution. 
All variables, except for salivary caffeine and blood glucose and lactate were assessed using a one-
way analysis of variance (ANOVA) with repeated measures. Salivary caffeine concentration and 
blood glucose and lactate were analysed with a two-way ANOVA with repeated measures. 
Sphericity was analysed by Mauchly’s test of sphericity followed by the Greenhouse-Geisser 
adjustment where required. Where any differences were identified, pairwise comparisons with 
Bonferroni correction were used to show where they lay. The data was analysed using IBM SPSS 
Statistics for Windows, Version 24.0 (Armonk, NY: IBM Corp.). Furthermore, 95% confidence 
intervals (95%CI) and effect sizes using partial eta squared ( 2
P
 ), defined as trivial (<0.10), small 
(0.10-0.24), moderate (0.25-0.39) or large (0.40), and Cohen’s d, defined as trivial (<0.20), small 
(0.20-0.49), moderate (0.50-0.79) or large (0.80)  according to the cut-offs suggested by Cohen19, 
were also calculated. In addition, the changes in race performance were standardized and expressed 
as a factor of the smallest worthwhile change, based on Cohen’s effect size principle. 
 
Results 
 
The results show a large main effect for trial (F2,24=9.524; P=0.001; 2P =0.44; Figure 1) with race 
completion time being faster following the ingestion of COF (04:35:37 ± 00:10:51 mm:ss) 
compared with DEC (04:39:14 ± 00:11:21  mm:ss; P=0.018; 95%CI: -0.11, -0.01; d=0.32) and 
PLA (04:41:00 ± 00:09:57 mm:ss; P=0.006; 95%CI: -0.15, -0.03; d=0.51). However, only a trivial 
difference between DEC and PLA was observed (P=0.602; 95%CI: -0.09, 0.03; d=0.17). Overall, 
race performance was improved by 1.9 ± 1.7% (95%CI: 1, 2.8) and 1.3± 1.4% (95%CI: 0.5, 2.0) 
following the ingestion of COF, compared with PLA and DEC respectively with a 0.6± 1.6% 
(95%CI: -0.2, 1.5) improvement following DEC compared with PLA. Furthermore, no order effect 
was observed (F2,24=0.041; P=0.959; 2P =0.00). 
 
A large trial and time interaction for salivary caffeine concentration was observed (F2,21=24.260; 
P<0.001; 2P =0.69; Figure 2) with a very large increase (6.40 ± 1.57 μg·ml
-1, 95%CI: 5.5, 7.3, 
d=3.86) in salivary caffeine concentration between pre-race and post-warm-up observed following 
the ingestion of COF. In contrast, only small changes were observed during DEC (0.87 ± 1.68 
μg·ml-1, 95%CI: -0.1, 1.8, d=0.43) and PLA (0.83 ± 2.06 μg·ml-1, 95%CI: -0.3, 2.0, d=41). Only 
trivial differences between trials for blood glucose (F2,24=0.177; P=0.839; 2P =0.02; Table 1) and 
lactate (F2,24=2.584; P=0.096; 2P =0.18; Table 1), and maximum heart rate (F1,10=1.345; P=0.286; 
2
P
 =0.13; Table 1) were observed. 
 
Discussion 
 
The aim of the present study was to determine the effect of ingesting caffeinated coffee on one-
mile (1609 m) race performance. The main findings are that the ingestion of COF markedly 
increased salivary caffeine concentration and improved one-mile race performance compared with 
DEC and PLA. In addition, blood glucose and lactate concentration, and maximal heart rate were 
unaffected by the ingestion of COF or DEC. 
 
Following the ingestion of caffeinated coffee race performance was improved by 1.9% and 1.3% 
compared with PLA and DEC respectively. The ergogenic benefits of caffeine ingestion are well 
documented (e.g.3,21). However, fewer studies have documented the effects of coffee ingestion. In 
support of the findings of the present study, Wiles et al.8 reported that the ingestion of 3 g of 
caffeinated coffee, containing approximately 150-200 mg of caffeine, improved 1500 m treadmill 
running performance by 4.2 s (1.4%) when compared with decaffeinated coffee. Similarly, 
Hodgson et al.6 demonstrated that coffee and caffeine ingestion improved time trial performance 
by approximately 5%. Richardson and Clarke9 also reported that resistance exercise performance 
was improved by 22% following coffee ingestion, when compared with a placebo. Furthermore, 
Trexler et al.7 reported that caffeine and coffee ingestion improved total work performed during 
repeated sprints (95%CI: 40, 219 J). In contrast, Clarke et al.20 observed that the ingestion of coffee 
had little effect on repeated sprint cycling performance in relatively untrained males. Graham et 
al.5 previously suggested that the bioactive compounds in coffee, such as chlorogenic acids, may 
attenuate the ergogenic effect of caffeine. However, more recent studies6,7,14 have reported both 
coffee and caffeine ingestion yield similar benefits for exercise performance, most likely through 
the antagonistic effect on adenosine receptors reducing symptoms of central fatigue1. One potential 
reason for the inconsistent findings is training status. It is apparent that caffeine and coffee is less 
effective for non-trained individuals participating in high-intensity exercise12, possibly due to 
trained athletes, like the participants in the present study, having more muscle mass than 
recreational athletes and the concentration of adenosine receptors (the hypothesised primary target 
of caffeine2) appearing to be higher in trained compared to untrained individuals21. In addition, the 
high variability in performance that is typical for untrained subjects may also contribute. 
 
Although the purpose of this study was not to determine the mechanism of coffee action, adenosine 
antagonism, enhanced motor unit recruitment and reduced perception of pain and exertion have 
been proposed to explain the effects of caffeine supplementation on sport performance2. However, 
since caffeine interacts with many tissues, it is difficult to independently investigate its effects on 
the central and peripheral nervous systems, and metabolism22. When specifically examining 
exercise of the nature in the present study, the primary mechanisms by which caffeine exerts its 
ergogenic effects are considered to arise from the antagonism of adenosine receptors leading to an 
increase in neurotransmitter release and motor unit firing rates, pain suppression, reduced fatigue 
and improved neuromuscular performance2. Another possible mechanism through which caffeine 
may improve performance is by increasing the secretion of β-endorphins23, which may, at least 
partially, explain the mechanism by which caffeine attenuates pain sensation24 and rating of 
perceived exertion25 during exercise, thereby decreasing perceptions of effort and improving 
performance, as observed in the present study.  
 
In addition to its impact on the central nervous system, caffeine can affect substrate utilization 
during exercise with a decrease in glycogen utilization and an increase in free fatty acid 
mobilization26. However, alterations in substrate utilization is unlikely to mediate performance 
changes in the present study due to fat metabolism representing a minor substrate and muscle 
glycogen not being limiting2. In addition, de Paulis, et al.27 demonstrated that coffee ingestion 
caused a blunted response of adrenaline which was attributed to chlorogenic acids antagonising 
the binding of caffeine to adenosine receptors. Furthermore, Hodgson, et al.6 reported that the 
increase in glucose, fatty acids and glycerol observed when ingesting caffeine had an attenuated 
response following coffee ingestion, which was attributed to other compounds in coffee inducing 
subtle effects on the antagonism of A1 and A2A adenosine receptors. Despite these findings, the 
performance improvements observed by Hodgson, et al.6 were similar for both caffeine and coffee 
leading the authors to conclude coffee ingestion may alter the metabolic effects, but not the 
ergogenic effects on performance. In support of this observation, McLellan and Bell14 and Trexler 
et al.7 reported similar performance benefits from ingesting coffee and caffeine. However, in the 
present study no differences in blood glucose and lactate concentrations, and heart rate were 
observed, although these values were comparable with previous studies5,8,14. Overall, it is probable 
that coffee and caffeine supplementation enhances physical performance via a combined effect on 
both the central and peripheral systems.  
 
The present study is not without limitations. The use of a 24-hour dietary record to ensure pre-trial 
standardisation, whilst being an acceptable method and a good reflection of standard nutritional 
practice, there may be some concern about the accuracy. In addition, the baseline salivary caffeine 
concentrations suggest that caffeine was not abstained from prior to each trial. However, both 
factors are likely to provide a more ecologically valid condition and represent typical pre-race 
preparation. A further potential limitation is the wide range of the participants' habitual caffeine 
intake, although Gonçalves et al.28 recently demonstrated that during ~30 min cycling time trials, 
performance was not influenced by habitual caffeine consumption. 
 
Practical Implications 
 
The coefficient of variation (CV) for running performance at distances between 1500 m and 10,000 
m for elite males has been reported to be 1.4% (90%CI: 1.2-1.6)29 and the smallest worthwhile 
enhancement in performance of similar distances to be 0.3-0.5 of the CV29. In the present study, 
based on the placebo condition, this corresponds to a 1.01-2.25 s improvement in the time taken 
to complete the mile. Therefore, the performance improvements observed [vs. PLA: 5.38 ± 4.75 s 
(95%CI: 2.80, 7.97); vs. DEC: 3.62 ± 3.84 s (95%CI: 1.53, 5.70)] following the ingestion of 300 
ml of caffeinated coffee providing 3 mg·kg-1 of caffeine 60 minutes before a race could be 
considered practically meaningful during actual competitions. However, athletes need to be aware 
that the type of coffee and brewing method alters the caffeine and chlorogenic acids content10 and 
inter-individual variation in pharmacodynamic and pharmacokinetic polymorphisms30 may cause 
variation in the responses to caffeine and its ergogenic effects. 
 
Conclusion 
 
In conclusion, the ingestion of caffeinated coffee 60 minutes before a one-mile race markedly 
increased salivary caffeine concentration and improved race performance compared with 
decaffeinated coffee and a placebo solution. These findings suggest that the ingestion of 
caffeinated coffee is a suitable source of caffeine prior to a one-mile running race. 
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Figure 1: Mean and individual race completion times for each condition.  
* COF time faster than PLA (d=0.32) and DEC (d=0.51). 
 
 
 
 
* 
Baseline Post-Warm-Up Post-Race
S
a
li
v
a
ry
 C
a
ff
e
in
e
 (

g
·m
l-
1
)  
0
1
2
3
4
5
6
7
8
9
10
11
COF
DEC
PLA
 
 
Figure 2: Mean (±SD) salivary caffeine concentration during each condition. 
* COF higher than PLA (d=2.34) and DEC (d=2.47). 
# COF higher than PLA (d=1.99) and DEC (d=1.83). 
 
 
 
 
 
 
 
 
# * 
Table 1: Blood glucose and lactate at baseline, post-warm-up and post-race, and heart rate post-
warm-up and maximum value achieved during each race. 
 
 COF DEC PLA 
Blood Glucose (mmol·l-1)    
Baseline 4.64 ± 0.71 4.33 ± 0.83 4.72 ± 0.54 
Post-Warm-Up 4.86 ± 0.52 4.78 ± 0.48 4.85 ± 0.79 
Post-Race 7.47 ± 1.17 7.54 ± 1.15 7.14 ± 0.92 
Blood Lactate (mmol·l-1)    
Baseline 1.94 ± 0.52 1.91 ± 0.64 1.66 ± 0.45 
Post-Warm-Up 4.07 ± 0.99 3.99 ± 1.11 3.99 ± 1.08 
Post-Race 14.35 ± 3.52 13.42 ± 3.26 12.40 ± 3.02 
Heart Rate (beats·min-1)    
Post-Warm-Up 104 ± 11 104 ± 13 106 ± 5 
Maximal  187 ± 10 182 ± 17 190 ± 7 
 
 
